GH News and Press, Guardant Health Inc. From 03/22/24

2024-03-22 13:31:40 ET Summary GH can prove to the market they have a competitive product in Shield that can gain a foothold in the roughly 50m unscreened CRC patient population. Shield's strongest adherence rate, with the potential for on-par sensitivity submission within 18 mont...

2024-03-21 11:53:17 ET More on S&P 500 Index: Chairman Powell Hits A Grand Slam Home Run Despite What The Fed Says, The Policy Is Still 'Higher-For-Longer' The Fed Is More Dovish Than The Market Anticipates 32 “Breakthroughs” stocks by BofA ...

Not intended for distribution to U.S. newswire services or for dissemination in the U.S. RED DEER, AB / ACCESSWIRE / March 12, 2024 / Gamehost Inc. (TSX:GH) Management and Directors of Gamehost Inc. (the "Company") present results for the twelve and three months ended December 31, 2023 (the ...

Findings from the first ‘Closing the Gap: CRC Screening Insights’ survey, released during National Colorectal Cancer Awareness Month, suggest more convenient blood-based testing could transform colorectal cancer screening by encouraging the 50 million Americans behind in screening t...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 3.3% to $4.09 on volume of 136,598,120 shares Nikola Corporation (NKLA) rose 8.9% to $0.7643 on volume of 134,299,966 shares Rivian Automotive Inc. (RIVN) fell 12.1% to $10.07 on...

2024-02-25 10:40:00 ET Summary Aristotle Capital Management is an independent/employee-owned investment management organization that specializes in equity and fixed income portfolio management for institutional and advisory clients worldwide. For the fourth quarter of 2023, Aristo...

2024-02-23 15:28:35 ET Cancer test maker Guardant Health ( NASDAQ: GH ) reached a new 52-week low on Friday after the company reported better-than-expected financials for Q4 2023 but issued in-line guidance, disappointing investors.... Read the full article on Seeking Alpha ...

2024-02-22 23:43:08 ET Guardant Health, Inc. (GH) Q4 2023 Results Earnings Conference Call February 23, 2024, 04:30 PM ET Company Participants Carrie Mendivil - Investor Relations, Gilmartin Group LLC Helmy Eltoukhy - Chairman and co-Chief Executive Officer AmirA...

2024-02-22 16:31:52 ET More on Guardant Health Guardant Health: Vast Market Opportunity, Challenging Valuation Guardant Health Q4 2023 Earnings Preview Guardant Health forecasts upbeat Q4, 2023 revenue guidance Seeking Alpha’s Quant Rating on Guardant ...

Full year 2023 revenue growth of 25% driven by clinical volume growth of 39% Expects full year 2024 revenue to be in the range of $655 to $670 million Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter and f...